Addiction Medicine, Article

Reduction of opioid prescribing through the sharing of individual physician opioid prescribing practices

a b s t r a c t

Background: Drug overdoses are the most common cause of accidental death in the United States, with the ma- jority being attributed to opioids. High per capita opioid prescribing is correlated with higher rates of Opioid abuse and death. We aimed to determine the impact of sharing individual prescribing data on the rates of Opioid prescriptions written for patients discharged from the emergency department (ED).

Methods: This was a pre-post intervention at a single community ED. We compared opioid prescriptions written on patient discharge before and after an intervention consisting of sharing individual and comparison prescribing data. Clinicians at or over one standard deviation above the mean were notified via standard template electronic communication.

Results: For each period, we reported the median number of monthly prescriptions written by each clinician, ac- counting for the total number of patient discharges. The pre-intervention median was 12.5 prescriptions per 100 patient discharges (IQR 10-19) compared to 9 (IQR 6-11) in the post-intervention period (p b 0.001). This rep- resents a 28% reduction in the overall rate of opioid prescriptions written per patient discharged. Using interrupted Time series analysis for monthly rates, this was associated with a reduction in opioid prescriptions, showing a decrease of almost 9 prescriptions for every 100 discharges over the 6 months of the study (p = 0.032).

Conclusion: Our study demonstrates the sharing of individual opioid prescribing data was associated with a re- duction in opioid prescribing at a single institution.

(C) 2018

Introduction

Despite significant time, funding and resources dedicated to ad- dressing the opioid epidemic, mortality from opioids still grows in the United States (US). Currently the leading cause of accidental death in the US is drug overdose, the majority of which are attributed to opioids. In 2015, 63.1% of drug overdose deaths involved opioids, nearly one third of which were prescription drug related [1].

One area of primary prevention with the potential to impact the opi- oid crisis is the prescription of opioid medications by emergency physi- cians. While emergency physicians account for an overall low total number of opioid prescriptions written for patients compared to other

? This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.This work has previously been presented in abstract form at the Society for Academic Emergency Medicine in Orlando, Florida, in May 2017.

* Corresponding author at: One Deaconess Road WCC-2, Boston, MA 02215, USA.

E-mail address: klboyle@bidmc.harvard.edu (K.L. Boyle).

1 Co-first authors.

specialties, they are high frequency providers and substantial variation exists among individual physicians [2]. Decreasing excessive or unnec- essary prescribing of opioid medications from the ED may therefore have the potential to reduce subsequent opioid use, misuse, and overdose.

It has been demonstrated that opioid naive patients who receive a prescription for an opioid medication on discharge from the ED are at increased risk of continuing to receive prescriptions for opioids one year later [3]. Similarly, patients who receive opioid analgesics versus NSAIDs after motor vehicle collision have no difference in risk for mod- erate to severe Musculoskeletal pain at six weeks after discharge from the ED, but patients who were prescribed opioid medications were more likely to report use of prescription opioid medications at six week follow-up [4]. Finally, opioid prescription medications may also play a role in mortality attributed to illicit opioids as Heroin users are often introduced to opioids in the form of prescription opioid medica- tion prior to using heroin [5]. Given risks of future opioid Prescription use, misuse, and transition to heroin use, limiting physician prescribing of opioid medications may decrease mortality from opioids.

https://doi.org/10.1016/j.ajem.2018.09.052

0735-6757/(C) 2018

There is evidence that comparing physician behavior to peers through the sharing of individual performance data can be an effective method to improve practice behavior [6]. A recent study by Michael et al. demonstrated that self-perception of opioid prescribing by emer- gency physicians was frequently underestimated [7]. In the randomized controlled trial, the group of emergency physicians who underestimated their prescribing of opioids who were shown individual and group opioid prescribing metrics had a larger magnitude decrease in overall opioid prescribing compared with emergency physicians who had an accurate estimate of their prescribing practices and controls [7]. We hypothesized that the sharing of individual provider opioid pre- scribing patterns – along with group prescribing for comparison – would decrease prescribing of opioids from a community ED.

Methods

Study design

The study was a pre-post intervention. It was approved by the insti- tutional review board at Beth Israel Deaconess Hospital-Plymouth.

Study setting and population

The study took place at a single community hospital ED (47,000 pa- tients/year) in suburban Massachusetts. The intervention group consisted of all physician and advanced practice (nurse practitioner and physician assistant) clinicians who staffed the ED of the community hospital where the intervention was deployed.

Study protocol

The pre-intervention period was from March 1, 2015 to August 31, 2015. The intervention was deployed on September 9, 2015 and quar- terly thereafter. September 1, 2015, through September 30, 2015 was considered a washout period. The post-intervention period was October 1, 2015 through March 30, 2016. Our study was planned and imple- mented prior to an October 2016 Massachusetts law mandating the use of the prescription drug-monitoring database prior to prescribing opioid medications. While prior legislation did also require the use of the prescription drug-monitoring database, a regulatory exception was worked out between emergency physicians in Massachusetts and the Department of Public Health. This exception was made for providers in an ED who did not anticipate writing a prescription for more than a five-day supply of a controlled substance or in situations when emer- gency care is required and utilization of the prescription monitoring program would be likely to result in Patient harm in the professional opinion of the provider. Because of this exception, it was encouraged but not standard practice for emergency physicians to utilize the data- base before writing prescriptions.

For each period, the number of prescriptions written by each clini- cian per 100 patients discharged and the number of pills per prescrip- tion were documented. The following isolated and combination product opioids in pill form were recorded: hydrocodone, oxycodone, hydromorphone, morphine, tramadol, and codeine. Group data was reviewed at staff meeting on a quarterly basis. Individual metrics show- ing each clinician’s data with a comparison to the group mean was dis- tributed to clinicians, highlighting those at or over one standard deviation above the mean. For all clinicians identified as outliers, data were reviewed individually via standard template electronic communi- cation. Basic education about the association of prescribing practices with mortality from opioids was provided at staff meetings. Addition- ally, prescribing guidelines were provided to support clinicians in their decision not to prescribe opioids to patients with high-risk features.

Key outcome measures

Descriptive statistics of median opioid prescriptions (monthly rates per 100 discharges) with inter-quartile range (IQR) and median pills per prescription were compared using Wilcoxon Signed Rank Test.

Our primary outcome was the change in prescribing at the provider level after the intervention using an Interrupted Time Series (ITS) anal- ysis, which is a quasi-experimental approach for evaluating longitudinal effects of interventions. We divided the trial period into two time seg- ments – before and after implementation of the intervention. In ITS ap- proach, two parameters define each segment: level and trend. The level is the value of the series at the beginning of a given time interval (inter- cept). The trend is the rate of change of a measure (in other words, the slope) during a segment. In segmented regression analysis, each seg- ment of the series can exhibit both a level and a trend. A change in level indicates an abrupt intervention effect. A change in trend, defined by the change in the slope of the segment after the introduction of the pathway, indicates a more gradual change. Using an ITS approach, we employed Autoregressive Integrated Moving Average (ARIMA) models to estimate the changes in level and trend following the intervention. For the graphical analysis of the ARIMA model, we employed a linear de- piction of the slope.

As a secondary analysis, we evaluated both the mean total number of opioid prescriptions per 100 patients discharged and mean number of pills per opioid prescription per month pre- and post-intervention by each individual provider.

Data analysis

Analyses were performed using SPSS software (version 21, SPSS Inc.

Chicago, Illinois). The level of significance was 0.05.

Results

The pre-intervention median was 12.5 opioid prescriptions per 100 patient ED discharges (IQR 10-19) compared to 9 (IQR 6-11) in the post-intervention period (p b 0.001). This represents a 28% reduction in the overall rate of opioid prescriptions written per patient discharged. The median number of patients discharged each month per physician before the intervention was 119 (IQR 49-155) compared to 107 (IQR 53-151) post intervention (p = 0.75). Table 1 summarizes the per capita opioid prescribing and demonstrates a statistically significant de- crease in the overall number of pills written per prescription in the in- tervention group.

When stratified by type of clinician, the median number of opioid prescriptions for mid-level providers (physician assistants and nurse- practitioners) was 22 per 100 discharges pre-intervention and 9 per 100 discharges post intervention (p = 0.109); for physicians the me- dian was 12 opioid prescriptions per 100 discharges pre-intervention and 8 opioid prescriptions per 100 discharges post intervention (p = 0.001).

Using ITS analysis for monthly Prescription rates, the post- intervention slope plotting prescription rates over time showed a non- statistically significant increase of about 0.4 opioid prescriptions per 100 patients discharged each month in the time period before the inter- vention (p = 0.324) and a statistically significant decrease of 0.5 pre- scriptions per 100 patients discharged per month after the intervention (p = 0.009), for a total decrease of almost 9 prescriptions per 100 discharges over the six months of the study. The intercept re- vealed a significant immediate decrease in opioid prescriptions from pre- to post-intervention (-0.96, p = 0.47). The monthly trend in opi- oid prescriptions is demonstrated in Fig. 1, and depicts a steady decrease in prescription rates in the post-intervention period.

We observed that the decreased in the rate of opioid prescriptions was also seen at the individual provider level. Fig. 2 demonstrates the change in mean opioid prescribing from pre- to post-intervention at

Table 1

Descriptive statistics of opioid prescriptions before versus after the intervention.

Before intervention

After intervention

p-value

Median [IQR]

Median [IQR]

Opioid prescriptions per 100 patients discharged per physician

12.5 [10-19]

9 [6-11]

b0.001

Opioid pills per prescription

17 [14-18]

15 [12-16]

0.145

Oxycodone prescriptions per 100 patients discharged per physician

8 [5-11.5]

4 [3-7]

b0.001

Oxycodone pills per prescription

16 [14-18]

13 [11-16]

0.006

Hydrocodone prescriptions per 100 patients discharged per physician

2 [1-5]

2 [1-4]

0.313

Hydrocodone pills per prescription

18 [15-22]

16 [12-23]

0.658

the individual provider level, along with the overall number of dis- charges for each provider during each time period. The majority of indi- vidual providers also prescribed fewer pills in the opioid prescription post-intervention compared with the pre-intervention period. Fig. 3 shows the average total number of opioid pills per prescription by each provider pre- and post-intervention.

Discussion

This study adds further support to the idea that an intervention based on sharing individual and group opioid prescribing data in the ED setting is associated with a decrease in the per-capita rate of pre- scriptions written for patients on ED discharge. The ITS approach allowed for the accounting of temporal trends, such as legislative pres- sure and the media exerting influence on physician opioid prescribing. It is important to note that the study predates the Massachusetts legis- lation from October 2016 mandating the use of the prescription drug- monitoring database prior to prescribing opioid medications.

Emergency physicians are in a unique position to promote change in the availability of opioid prescriptions and the expectations of patients towards receiving opioid medications on discharge from the ED. While emergency physicians generally prescribe small pill counts, they are high frequency providers and have the opportunity to impact a large number of patients. Recent work using a national sample of Medicare beneficiaries highlighted that higher emergency physician prescribing of opioids had a positive association with increased long-term opioid use [8]. Additionally, more than half of people reporting non-medical

prescription painkiller use state that they were given the medication by a friend or relative [9]. Therefore, reducing potentially unnecessary opioid prescriptions will likely benefit the safety of our community as a whole.

Our attempt to modify provider behavior focused on interventions with active feedback and peer comparison. Previous work by Meeker et al. reported a decrease in inappropriate Antibiotic prescriptions for upper respiratory tract infections by requiring a specific antibiotic justi- fication to be entered into the patient’s chart or by comparing provider prescription data to their peers, both of which were noted to have a so- cial motivation [10]. The passive, non-social measure of a suggested list of Alternative therapies did not produce a statistically significant change. The recent work by Michael et al. lends further support to this approach, and specifically supports the relevance of this approach to opioid prescribing in the ED [7].

Last year, Barnett et al. looked at the impact of a Massachusetts state policy intending to decrease the number of opioids prescribed by physi- cians in the state [11]. The Department of Public Health emailed all pre- scribers a report on the number of opioids they prescribed in the past year, as well as the mean and median rates for other clinicians in their specialty. Barnett found no evidence this intervention reduced opioid pre- scription rates among primary care physicians in Massachusetts com- pared with other states [11]. Our intervention was different in a number of important ways. First, providers received multiple, more frequent re- ports detailing their individual prescribing practices over a period of time. Additionally, the peer comparison was with colleagues who were working in the same ED. Finally, the physicians who were identified as

Image of Fig. 1

Fig. 1. Trend in median Opioid prescriptions over trial time period.

Average Opioid prescriptions per 100 discharged patients, per provider pre vs. post-intervention

40

35

30

25

20

15

10

5

0

350

300

250

200

150

100

50

0

pre-intervention post-intervention Discharges post-intervention Discharges pre-intervention

Fig. 2. Average of total Opioid prescriptions per 100 patients discharged by provider per month pre vs. post intervention (left axis), and total discharges per provider during each period (right axis).

outliers saw this reflected on their report and received additional feed- back and education. These important distinctions may have contributed to the reduced number of opioid prescriptions observed in our study com- pared to the Massachusetts Department of public health intervention.

Limitations

Our most notable limitation is that this is a single institution study, although we suspect our results are generalizable to many other com- munities EDs. Applying a similar intervention at academic centers could prove challenging given frequent resident turnover and the ex- tent to which these prescriptions are overseen by attending physicians. Similar limitations would exist for facilities that employ large numbers of locum tenens physicians.

Additionally, we do not have a control group for comparison. The focus around the opioid epidemic may have played a role in the

reduction of prescriptions seen in our study and limit the benefit of this intervention on a wider scale, although we hypothesize this to be additive to the external pressures placed on providers.

Finally, as Fig. 1 shows, there is an increase in per-capita prescribing seen after an initial sharp decline. Some of this is likely regression to the mean, but it will be important to track our prescriptions over a longer pe- riod of time. We anticipate that to remain effective, the intervention needs to continue to remind providers of the importance of appropriate opioid prescribing and our individual roles in managing the opioid epidemic.

Conclusion

In summary, our study demonstrates that interventions in the form of individualized feedback about personal opioid prescribing patterns with comparison to peers can reduce the number of opioid prescriptions

Average Opioid pills per prescriptions per provider, pre vs. post -intervention

25

20

15

10

5

0

Fig. 3. Average of total Opioid pill per prescription rates, prescribed by each provider per month pre vs. post intervention.

written by emergency physicians on patient discharge from a single community ED.

References

  1. Annual Surveillance Report of Drug-Related Risks and Outcomes. CDC National Cen- ter for Injury Prevention and Control. https://www.cdc.gov/drugoverdose/pdf/pubs/ 2017-cdc-drug-surveillance-report.pdf, Accessed date: 3 January 2018.
  2. Hoppe JA, Nelson LS, Perrone J, Weiner SG. prescribing opioids safely in the emer- gency department study I, prescribing opioids safely in the emergency department PSI. Opioid prescribing in a cross section of US emergency departments. Ann Emerg Med 2015;66(3):253-9 [e251].
  3. Hoppe JA, Kim H, Heard K. Association of emergency department opioid initiation with recurrent opioid use. Ann Emerg Med 2015;65(5):493-8.
  4. Beaudoin FL, Gutman R, Merchant RC, et al. Persistent pain after motor vehicle col- lision: comparative effectiveness of opioids vs nonsteroidal anti-inflammatory drugs prescribed from the emergency department- a propensity matched analysis. Pain 2017;Feb 158(2):289-95.
  5. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat 2014;71(7): 821-6.
  6. Davis DA, Thomson MA, Oxman AD, et al. Changing physician performance. A sys- tematic review of the effect of continuing medical education strategies. JAMA 1995;274(9):700-5.
  7. Michael SS, Babu KM, Androseki Jr C, Reznek MA. Effect of a data-driver intervention on opioid prescribing intensity among emergency department providers: a random- ized controlled trial. Acad Emerg Med 2018 May;25(5):482-93.
  8. Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physi- cians and risk of long-term use. N Engl J Med 2017;376(7):663-73.
  9. Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by fre- quency of past-year nonmedical use United States, 2008-2011. JAMA Intern Med 2014;174(5):802-3.
  10. Meeker D, Linder JA, Fox CR, Friedberg MR, Persell SD, Goldstein NJ, et al. Effect of behavioral interventions on inappropriate Antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315(6):562-70.
  11. Barnett ML, Gray J, Zink A, Jena A. Coupling policymaking with evaluation- the case of the opioid crisis. N Engl J Med 2017;377(24):2306-9.

Leave a Reply

Your email address will not be published. Required fields are marked *